Chronic conditions patient’s perception of post-COVID-19 pandemic teleconsulting continuation in primary care clinics: a qualitative descriptive study

Poitras, Marie-Ève; Poirier, Marie-Dominique; Couturier, Yves; Vaillancourt, Vanessa T.; Cormier, Caroline; Gauthier, Gilles; Massé, Sylvie; Gendron, Audrey; Oswick, Megan L; Morin, Anaëlle; Blanchette, Patricia; Bernier, Andréanne

doi:10.1136/bmjopen-2022-066871

Cited by 5 publications

(7 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such cases generally do not necessitate hospitalization at COVID-19designated medical facilities and can be adequately managed at home with appropriate medical guidance and monitoring. The heightened level of patient satisfaction observed in symptomatic individuals treated by HBIC is supported by an associated investigation conducted through a survey-based study (10,(16)(17)(18).…”

Section: Discussionmentioning

confidence: 90%

COVID-19 patient satisfaction and associated factors in telemedicine and hybrid system

Gashaw,

Alemu,

Constanzo

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

BackgroundThe quality assessment of the home-based isolation and care program (HBIC) relies heavily on patient satisfaction and length of stay. COVID-19 patients who were isolated and received HBIC were monitored through telephone consultations (TC), in-person TC visits, and a self-reporting application. By evaluating patient satisfaction and length of stay in HBIC, healthcare providers could gauge the effectiveness and efficiency of the HBIC program.MethodsA cross-sectional study design enrolled 444 HBIC patients who answered a structured questionnaire. A binary logistic regression model assessed the association between independent variables and patient satisfaction. The length of stay in HBIC was analyzed using Cox regression analysis. The data collection started on April (1–30), 2022, in Addis Ababa, Ethiopia.ResultsThe median age was 34, and 247 (55.6%) were females. A greater proportion (313, 70.5%) of the participants had high satisfaction. Higher frequency of calls (>3 calls) (AOR = 2.827, 95% CI = 1.798, 4.443, p = 0.000) and those who were symptomatic (AOR = 2.001, 95% CI = 1.289, 3.106, p = 0.002) were found to be significant factors for high user satisfaction. Higher frequency of calls (>3 calls) (AHR = 0.537, 95% CI = 0.415, 0.696, p = 0.000) and more in-person visits (>1 visit) (AHR = 0.495, 95% CI = 0.322, 0.762, p = 0.001) had greater chances to reduce the length of stay in the COVID-19 HBIC.Conclusion70.5% of the participants had high satisfaction with the system, and frequent phone call follow-ups on patients’ clinical status can significantly improve their satisfaction and length of recovery. An in-person visit is also an invaluable factor in a patient’s recovery.

show abstract

Section: Discussionmentioning

confidence: 90%

COVID-19 patient satisfaction and associated factors in telemedicine and hybrid system

Gashaw,

Alemu,

Constanzo

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…The absence of travel allowed patients to spend less time on their consultation in a primary care clinic. In addition, many patients reported not having to ask their employer to be released from work, not having to deal with unexpected road conditions (traffic jams, winter driving), losing time to find a parking space and waiting several minutes in a waiting room (Poitras et al, 2022).…”

Section: Advantages Of Digital Healthcare For Patients With Chronic D...mentioning

confidence: 99%

Navigating Chronic Disease Management with Digital Healthcare Solutions amidst the COVID-19 Pandemic: A Systematic Literature Review

Vratimos,

Champilomatis,

Farantos

2024

ESJ

View full text Add to dashboard Cite

Purpose: The purpose of this paper is to critically evaluate data collected from various studies on Chronic Disease Management during the COVID-19 pandemic and the emergence of Digital Healthcare as a means of providing innovative approaches to manage chronic diseases. Methodology: A systematic literature review was applied. Studies were found after a search in the Pubmed database with no publication date time limit, given that COVID–19 emerged in 2019. A Prisma diagram was created to record the way and the criteria by which we included and excluded studies for our research. Out of the 567 records identified through various sources 85 were used for a qualitative synthesis. Results: During the first wave of the pandemic, a significant reduction or complete cancellation of scheduled health appointments was observed. Shortages of medication used to manage chronic conditions were also observed at the beginning of the COVID-19 pandemic due to global supply chain disruptions. Governments acted rapidly at the beginning of the pandemic to promote the use of teleconsultations by introducing enabling legislation and revising laws ensuring continuity of care for people with chronic diseases, thus transitioning rapidly to remote care and monitoring. Conclusion: Telemedicine and involving community pharmacists in chronic patient management are key for sustained adherence. Long-term policies are vital to prevent pandemic-driven health disparities. Lessons should be derived for future preparedness, managing subsequent waves, and ensuring testing in primary care.

show abstract

“…This landscape is likely to have changed as a consequence of the COVID-19 pandemic, during which telemedicine became the predominant mode of diabetes consultations [ 195 ]. Although limited, the available evidence suggests that telemedicine is not inferior to face-to-face visits in diabetes care [ 195 , 196 ], and that primary care teams and patients have embraced it [ 197 , 198 ].…”

Section: Modern Management Of Diabetes With Cgm: a Challenge For Heal...mentioning

confidence: 99%

Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease

et al. 2023

View full text Add to dashboard Cite

Application of continuous glucose monitoring (CGM) has moved diabetes care from a reactive to a proactive process, in which a person with diabetes can prevent episodes of hypoglycemia or hyperglycemia, rather than taking action only once low and high glucose are detected. Consequently, CGM devices are now seen as the standard of care for people with type 1 diabetes mellitus (T1DM). Evidence now supports the use of CGM in people with type 2 diabetes mellitus (T2DM) on any treatment regimen, not just for those on insulin therapy. Expanding the application of CGM to include all people with T1DM or T2DM can support effective intensification of therapies to reduce glucose exposure and lower the risk of complications and hospital admissions, which are associated with high healthcare costs. All of this can be achieved while minimizing the risk of hypoglycemia and improving quality of life for people with diabetes. Wider application of CGM can also bring considerable benefits for women with diabetes during pregnancy and their children, as well as providing support for acute care of hospital inpatients who experience the adverse effects of hyperglycemia following admission and surgical procedures, as a consequence of treatment-related insulin resistance or reduced insulin secretion. By tailoring the application of CGM for daily or intermittent use, depending on the patient profile and their needs, one can ensure the cost-effectiveness of CGM in each setting. In this article we discuss the evidence-based benefits of expanding the use of CGM technology to include all people with diabetes, along with a diverse population of people with non-diabetic glycemic dysregulation. Supplementary Information The online version contains supplementary material available at 10.1007/s13300-023-01431-3.

show abstract

Chronic conditions patient’s perception of post-COVID-19 pandemic teleconsulting continuation in primary care clinics: a qualitative descriptive study

Cited by 5 publications

References 36 publications

COVID-19 patient satisfaction and associated factors in telemedicine and hybrid system

COVID-19 patient satisfaction and associated factors in telemedicine and hybrid system

Navigating Chronic Disease Management with Digital Healthcare Solutions amidst the COVID-19 Pandemic: A Systematic Literature Review

Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease

Contact Info

Product

Resources

About